APA (7th ed.) Citation

Tanada, M., Tamiya, M., Matsuo, A., Chiyoda, A., Takano, K., Ito, T., . . . Shiraishi, T. (2023). Development of Orally Bioavailable Peptides Targeting an Intracellular Protein: From a Hit to a Clinical KRAS Inhibitor. Journal of the American Chemical Society, 145(30), 16610-16620. https://doi.org/10.1021/jacs.3c03886

Chicago Style (17th ed.) Citation

Tanada, Mikimasa, et al. "Development of Orally Bioavailable Peptides Targeting an Intracellular Protein: From a Hit to a Clinical KRAS Inhibitor." Journal of the American Chemical Society 145, no. 30 (2023): 16610-16620. https://doi.org/10.1021/jacs.3c03886.

MLA (9th ed.) Citation

Tanada, Mikimasa, et al. "Development of Orally Bioavailable Peptides Targeting an Intracellular Protein: From a Hit to a Clinical KRAS Inhibitor." Journal of the American Chemical Society, vol. 145, no. 30, 2023, pp. 16610-16620, https://doi.org/10.1021/jacs.3c03886.